Boothbay Fund Management’s Traws Pharma TRAW Stock Holding History

Boothbay Fund Management’s Portfolio TRAW Stock Details TRAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$113K	Sell	133,936 -60,600	-31%	-$83.5K	﹤0.01%	2037
2026 Q1	$356K	Hold	194,536	–	–	﹤0.01%	1538
2025 Q4	$220K	Buy	+194,536	New	+$433K	﹤0.01%	1620
2025 Q2	–	Sell	-33,305	Closed	-$76.6K	–	1824
2025 Q1	$76.6K	Buy	33,305 +4,874	+17%	+$25.3K	﹤0.01%	1250
2024 Q4	$108K	Buy	+28,431	New	+$158K	﹤0.01%	1280
2021 Q2	–	Sell	-364	Closed	-$136K	–	2161
2021 Q1	$136K	Buy	+364	New	+$137K	0.01%	1442

Other funds holding TRAW

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

ABG

Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Boothbay Fund Management's TRAW Position: Q2 2026 in Review

Boothbay Fund Management reduced its Traws Pharma (TRAW) stake by 31% in Q2 2026, selling an estimated $83.5K and leaving 133,936 shares worth $113K. The position accounts for ﹤0.01% of the portfolio, ranked #2037.

Boothbay Fund Management first reported a position in TRAW in Q1 2021 and has held it in 6 quarters since. The position peaked at $356K in Q1 2026. 34 funds tracked by Wall St. Rank hold TRAW as of Q2 2026.

Boothbay Fund Management held 133,936 shares of Traws Pharma worth $113K as of Q2 2026.
Boothbay Fund Management sold 60,600 Traws Pharma shares in Q2 2026, an estimated $83.5K.
Traws Pharma made up ﹤0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #2037 holding.
Boothbay Fund Management first reported a position in Traws Pharma in Q1 2021 and has held it in 6 quarters since.
Boothbay Fund Management's Traws Pharma position peaked at $356K in Q1 2026.
34 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.